View Older Stories

Nov 12, 2025 06:39AM TD Cowen Reiterates Hold Rating on Avidity Biosciences (RNA)

Nov 10, 2025 05:44PM Prosensa Holding N.V. (RNA) Misses Q3 EPS by 13c

Nov 7, 2025 04:09AM Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral

Oct 29, 2025 02:27AM TD Cowen Downgrades Avidity Biosciences (RNA) to Hold

Oct 28, 2025 04:32PM Wolfe Research Downgrades Avidity Biosciences (RNA) to Peerperform

Oct 28, 2025 03:26AM RBC Capital Downgrades Avidity Biosciences (RNA) to Sector Perform

Oct 28, 2025 03:24AM Chardan Capital Markets Downgrades Avidity Biosciences (RNA) to Neutral

Oct 27, 2025 10:38AM Leerink Partners Downgrades Avidity Biosciences (RNA) to Market Perform

Oct 27, 2025 10:38AM Citi Downgrades Avidity Biosciences (RNA) to Neutral

Oct 27, 2025 07:30AM Roth/MKM Downgrades Avidity Biosciences (RNA) to Neutral

Oct 27, 2025 07:05AM Needham Downgrades Avidity Biosciences (RNA) to Hold

Oct 27, 2025 06:20AM H.C. Wainwright Downgrades Avidity Biosciences (RNA) to Neutral Post Novartis Acquisition

Oct 27, 2025 03:56AM Raymond James Downgrades Avidity Biosciences (RNA) to Market Perform

Oct 27, 2025 02:55AM Bernstein SocGen Group Downgrades Avidity Biosciences (RNA) to Market Perform

Oct 27, 2025 12:28AM Novartis to acquire Avidity Biosciences for $12 billion or $72 per share cash

Oct 26, 2025 11:32AM Novartis Said To Near Deal $70-per-share-plus Deal For Avidity Biosciences (RNA) - Bloomberg

Oct 13, 2025 09:01AM Avidity Biosciences delays del-zota filing to Q1 2026 after FDA meeting

Sep 17, 2025 12:57AM Roth/MKM Starts Avidity Biosciences (RNA) at Buy

Sep 15, 2025 07:28AM Avidity Biosciences (RNA) PT Raised to $87 at H.C. Wainwright

Sep 12, 2025 05:03PM Avidity Biosciences Inc. (RNA) files for 15M share offering

Sep 12, 2025 10:41AM Avidity Biosciences (RNA) PT Raised to $65 at BofA Securities

Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'

Sep 10, 2025 10:07AM TD Cowen Reiterates Buy Rating on Avidity Biosciences (RNA)

Sep 10, 2025 10:06AM Raymond James Reiterates Strong Buy Rating on Avidity Biosciences (RNA)

Aug 30, 2025 04:00PM Why public perception matters so much for biotech valuations

Aug 6, 2025 11:23AM Novartis (NVS) Made A Takeover Approach Avidity Biosciences (RNA) - FT

Aug 6, 2025 11:20AM Dyne Therapeutics Inc. (DYN) gains following Avidity Biosciences Inc. (RNA) Takeover Rumors, Up 24%

Jul 10, 2025 06:23AM Goldman Sachs Resumes Avidity Biosciences (RNA) at Buy

Jun 27, 2025 07:09AM Cantor Fitzgerald Reiterates Overweight Rating on Avidity Biosciences (RNA)

Jun 24, 2025 09:40AM TD Cowen's Best Smidcap Ideas 2025

Jun 17, 2025 05:54AM Wolfe Research Starts Avidity Biosciences (RNA) at Outperform

Jun 10, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Avidity Biosciences (RNA)

Jun 9, 2025 12:51PM Avidity Biosciences (RNA) PT Raised to $54 at BofA Securities

Jun 9, 2025 07:01AM Avidity Biosciences Inc. (RNA) Announces Positive Topline Phase 1/2 FORTITUDE Data Demonstrating Consistent Improvement Across Multiple Functional Measures Compared to Placebo in Del-Brax Treated FSHD

May 13, 2025 06:59AM Avidity Biosciences (RNA) PT Lowered to $68 at H.C. Wainwright

May 8, 2025 08:10PM Prosensa Holding N.V. (RNA) Misses Q1 EPS by 2c

Apr 8, 2025 09:02AM Avidity Biosciences (RNA) Receives Orphan Drug Designation in Japan for Delpacibart Etedesiran

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Mar 31, 2025 07:05AM Cantor Fitzgerald Reiterates Overweight Rating on Avidity Biosciences (RNA)

Mar 18, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Avidity Biosciences (RNA)

Mar 17, 2025 10:20AM Citi Reiterates Buy Rating on Avidity Biosciences (RNA)

Mar 17, 2025 07:08AM Avidity Biosciences (RNA) Announces Positive Topline Del-zota Data Demonstrating Consistent, Statistically Significant Improvements in Dystrophin, Exon Skipping and Creatine Kinase in DMD

Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more

Mar 11, 2025 04:12PM BMO Capital Starts Avidity Biosciences (RNA) at Outperform (correction)

Mar 7, 2025 07:08AM Scotiabank Starts Avidity Biosciences (RNA) at Sector Outperform

Feb 28, 2025 07:52AM Cantor Fitzgerald Reiterates Overweight Rating on Avidity Biosciences (RNA)

Feb 27, 2025 05:06PM Prosensa Holding N.V. (RNA) Reports In-Line Q4 EPS

Jan 6, 2025 03:32PM Avidity Biosciences Inc. (RNA) 1200 contracts of January 35 calls trade at 80c as share price up 4.3%

Jan 6, 2025 02:00PM 7 top biotech picks for 2025 according to Wells Fargo

Dec 22, 2024 04:00AM Barclays shares outlook for Biotech in 2025, names preferred stocks

View Older Stories